Financial News

Recent Quotes

My Watchlist

Indicators

Overview

Week In Review: Shanghai Regor To Discover Metabolic Therapies For Lilly In $1.55 Billion Deal

By: TalkMarkets

December 11, 2021 at 15:30 PM EST

Regor Therapeutics entered a $1.55 billion research pact with Eli & Lilly to discover therapies for metabolic disorders. Meanwhile, Beijing Avistone Pharma received a $200 million investment led by Vivo Capital to combine with Pearl Biotech.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Week In Review: Shanghai Regor To Discover Metabolic Therapies For Lilly In $1.55 Billion Deal

Popular Pages